This inventor holds 20 USPTO granted patents and 1 published patent application and 3 EPO patents, primarily in HIV and Hepatitis C Inhibitors. Top assignees: Boehringer Ingelheim (Canada) Ltd., Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharmaceuticals, Inc.. Active years: 2000-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Oka, CA (2000 - 2003)
- St. Placide, CA (2008)
- St-Placide, CA (2009 - 2012)
- Laval, CA (2010 - 2013)
Company Filing History:
11 out of 62 
5 out of 1,564 
1 out of 278 
Years Active: 2000-2013
Areas of Expertise:
Title: The Innovative Contributions of Anne-Marie Faucher
Introduction: Anne-Marie Faucher, a prominent inventor based in Oka, Canada, has made significant strides in the field of pharmaceuticals. With a remarkable portfolio of 20 patents, Faucher's work primarily focuses on the development of compounds that serve as inhibitors of HIV replication, showcasing her dedication to advancing medical science and helping those affected by this virus.
Latest Patents: Among her most recent innovations, Anne-Marie has developed two notable patents. The first pertains to inhibitors of HIV replication, characterized by compounds of a specific formula where various elements, denoted as R, A, X, and Y, are defined for their efficacy. The second patent focuses on non-nucleoside reverse transcriptase inhibitors, again utilizing a carefully structured formula for the compounds that target both wild type and mutated strains of HIV. These contributions play a crucial role in enhancing treatment options for many individuals living with HIV.
Career Highlights: Throughout her career, Anne-Marie has worked with renowned pharmaceutical companies. Notably, she has been associated with Boehringer Ingelheim Ltd. in Canada and Boehringer Ingelheim International GmbH. Her tenure with these organizations has allowed her to hone her expertise while contributing to groundbreaking research in antiviral drugs.
Collaborations: Anne-Marie Faucher has collaborated with esteemed colleagues in her field, including Youla S. Tsantrizos and Teddy Halmos. These partnerships have fostered a rich environment for innovative thinking and have undoubtedly enhanced the quality and impact of her research.
Conclusion: In summary, Anne-Marie Faucher's achievements as an inventor are noteworthy, particularly her contributions to HIV research through her patents. Her work not only reflects her commitment to science but also underscores the importance of collaboration in driving innovation. As she continues her journey, the medical community eagerly anticipates further advancements from this talented inventor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile